Generic Fosamax Approved The U.S. Food and Drug Administration today
Generic Fosamax Approved
The U.S. Food and Drug Administration today approved the first generic versions of Fosamax (alendronate sodium tablets), used to treat osteoporosis, a condition that causes thinning and weakening of a person's bones.